메뉴 건너뛰기




Volumn 32, Issue 1, 2006, Pages 149-156

Abetimus sodium (Riquent) for the prevention of nephritic flares in patients with systemic lupus erythematosus

Author keywords

[No Author keywords available]

Indexed keywords

ABETIMUS; CYCLOPHOSPHAMIDE; DEOXYRIBONUCLEASE; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; STEROID;

EID: 33344458515     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.11.001     Document Type: Review
Times cited : (18)

References (16)
  • 1
    • 0017337322 scopus 로고
    • Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis
    • J.B. Winfield, I. Faiferman, and D. Koffler Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis J Clin Invest 59 1977 90 96
    • (1977) J Clin Invest , vol.59 , pp. 90-96
    • Winfield, J.B.1    Faiferman, I.2    Koffler, D.3
  • 2
    • 0025374697 scopus 로고
    • Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus
    • E.J. ter Borg, G. Horst, and E.J. Hummel Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus Arthritis Rheum 33 1990 634 643
    • (1990) Arthritis Rheum , vol.33 , pp. 634-643
    • Ter Borg, E.J.1    Horst, G.2    Hummel, E.J.3
  • 3
    • 0032493059 scopus 로고    scopus 로고
    • Antibodies to DNA
    • B.H. Hahn Antibodies to DNA N Engl J Med 338 1998 1359 1368
    • (1998) N Engl J Med , vol.338 , pp. 1359-1368
    • Hahn, B.H.1
  • 4
    • 0025196075 scopus 로고
    • Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus
    • M. Schneider, T. Berning, and M. Waldendorf Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus J Rheumatol 17 1990 900 907
    • (1990) J Rheumatol , vol.17 , pp. 900-907
    • Schneider, M.1    Berning, T.2    Waldendorf, M.3
  • 5
    • 0029980225 scopus 로고    scopus 로고
    • High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus
    • M. Funauchi, S. Ikoma, and H. Enomoto High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus Intern Med 35 1996 367 372
    • (1996) Intern Med , vol.35 , pp. 367-372
    • Funauchi, M.1    Ikoma, S.2    Enomoto, H.3
  • 6
    • 0029965906 scopus 로고    scopus 로고
    • Intravenous immune globulin therapy of lupus nephritis: Use of pathogenic anti-DNA-reactive IgG
    • F. Silvestris, O. D'Amore, and P. Cafforio Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti-DNA-reactive IgG Clin Exp Immunol 104 1996 91 97
    • (1996) Clin Exp Immunol , vol.104 , pp. 91-97
    • Silvestris, F.1    D'Amore, O.2    Cafforio, P.3
  • 7
    • 4244086326 scopus 로고
    • Updated phase I clinical results with an idiotypic vaccine (3E10) for systemic lupus erythematosus (SLE) [abstract]
    • M.L. Lee, F. Spertini, and A. Leimgruber Updated phase I clinical results with an idiotypic vaccine (3E10) for systemic lupus erythematosus (SLE) [abstract] Arthritis Rheum 8 1995 S303
    • (1995) Arthritis Rheum , vol.8 , pp. 303
    • Lee, M.L.1    Spertini, F.2    Leimgruber, A.3
  • 8
    • 0033043318 scopus 로고    scopus 로고
    • Recombinant human DNase I (rhDNase) in patients with lupus nephritis
    • J.C. Davis, S. Manzi, and C. Yarboro Recombinant human DNase I (rhDNase) in patients with lupus nephritis Lupus 8 1999 68 76
    • (1999) Lupus , vol.8 , pp. 68-76
    • Davis, J.C.1    Manzi, S.2    Yarboro, C.3
  • 9
    • 0029073665 scopus 로고
    • Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis
    • D.S. Jones, P.A. Barstad, and M.J. Feild Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis J Med Chem 38 1995 2138 2144
    • (1995) J Med Chem , vol.38 , pp. 2138-2144
    • Jones, D.S.1    Barstad, P.A.2    Feild, M.J.3
  • 10
    • 0029995138 scopus 로고    scopus 로고
    • Pharmacologic intervention in antibody mediated disease
    • S.M. Coutts, M.L. Plunkett, and G.M. Iverson Pharmacologic intervention in antibody mediated disease Lupus 5 1996 158 159
    • (1996) Lupus , vol.5 , pp. 158-159
    • Coutts, S.M.1    Plunkett, M.L.2    Iverson, G.M.3
  • 11
    • 0031055675 scopus 로고    scopus 로고
    • Reduction in circulating dsDNA antibody titer after administration of LJP 394
    • M.H. Weisman, H.G. Bluestein, and C.M. Berner Reduction in circulating dsDNA antibody titer after administration of LJP 394 J Rheumatol 24 1997 314 318
    • (1997) J Rheumatol , vol.24 , pp. 314-318
    • Weisman, M.H.1    Bluestein, H.G.2    Berner, C.M.3
  • 12
    • 0037331980 scopus 로고    scopus 로고
    • LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study
    • D. Alarcón-Segovia, J.A. Tumlin, and R.A. Furie LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study Arthritis Rheum 48 2003 442 454
    • (2003) Arthritis Rheum , vol.48 , pp. 442-454
    • Alarcón-Segovia, D.1    Tumlin, J.A.2    Furie, R.A.3
  • 13
    • 12744275048 scopus 로고    scopus 로고
    • Abetimus sodium: A new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease
    • M.H. Cardiel Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease Expert Opin Investig Drugs 14 2005 77 88
    • (2005) Expert Opin Investig Drugs , vol.14 , pp. 77-88
    • Cardiel, M.H.1
  • 14
    • 20244383590 scopus 로고    scopus 로고
    • Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus
    • M.D. Linnik, J.Z. Hu, and K.R. Heilbrunn Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus Arthritis Rheum 52 2005 1129 1137
    • (2005) Arthritis Rheum , vol.52 , pp. 1129-1137
    • Linnik, M.D.1    Hu, J.Z.2    Heilbrunn, K.R.3
  • 15
    • 2942703965 scopus 로고    scopus 로고
    • LJP 394 (abetimus sodium, Riquent®) in the management of systemic lupus erythematosus
    • D.J. Wallace, and J.A. Tumlin LJP 394 (abetimus sodium, Riquent®) in the management of systemic lupus erythematosus Lupus 13 2004 323 327
    • (2004) Lupus , vol.13 , pp. 323-327
    • Wallace, D.J.1    Tumlin, J.A.2
  • 16
    • 0141849087 scopus 로고    scopus 로고
    • Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo
    • V. Strand, C. Aranow, and M.H. Cardiel Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo Lupus 12 2003 677 686
    • (2003) Lupus , vol.12 , pp. 677-686
    • Strand, V.1    Aranow, C.2    Cardiel, M.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.